DOI QR코드

DOI QR Code

The Use of Recombinant Human Bone Morphogenic Protein-2 (rhBMP-2) in Treatment for Cysts of the Oral and Maxillofacial Regions

  • Lee, Jong-Bum (Division of Oral and Maxillofacial Surgery, Department of Dentistry, Dong-A University Medical Center) ;
  • Kim, Taek-Woo (Division of Oral and Maxillofacial Surgery, Department of Dentistry, Dong-A University Medical Center) ;
  • Ryu, Seok-Hwan (Division of Oral and Maxillofacial Surgery, Department of Dentistry, Dong-A University Medical Center) ;
  • Shin, Dong-Yoon (Division of Oral and Maxillofacial Surgery, Department of Dentistry, Dong-A University Medical Center) ;
  • Ryu, Hyun-Ho (Division of Oral and Maxillofacial Surgery, Department of Dentistry, Dong-A University Medical Center) ;
  • Park, Seok-Yong (Division of Oral and Maxillofacial Surgery, Department of Dentistry, Dong-A University Medical Center) ;
  • Shin, Young-Cho (Division of Oral and Maxillofacial Surgery, Department of Dentistry, Dong-A University Medical Center) ;
  • Kim, Bok-Joo (Division of Oral and Maxillofacial Surgery, Department of Dentistry, Dong-A University Medical Center) ;
  • Hwang, Hee-Seong (Division of Oral and Maxillofacial Surgery, Department of Dentistry, Dong-A University Medical Center) ;
  • Kim, Chul-Hoon (Division of Oral and Maxillofacial Surgery, Department of Dentistry, Dong-A University Medical Center)
  • Received : 2013.07.29
  • Accepted : 2013.11.08
  • Published : 2014.01.30

Abstract

The purpose of this study is to report on five cases treated with bone graft using recombinant human bone morphogenetic protein-2 (rhBMP-2) on jaw defects after cyst enucleation. We performed bone graft with BMP (rhBMP-2+${\beta}$-tricalcium phosphate/hydroxyapatite) wrapped with a collagen sponge on jaw defects after cyst enucleation. Postoperative panoramic radiographs were taken periodically. After 1 to 12 months, bone remodeling was observed in the jaw defect area. In our cases, there were few signs or symptoms of recurrence of the cyst during the follow-up period.

Keywords

References

  1. Jones AV, Craig GT, Franklin CD. Range and demographics of odontogenic cysts diagnosed in a UK population over a 30-year period. J Oral Pathol Med 2006;35:500-7. https://doi.org/10.1111/j.1600-0714.2006.00455.x
  2. Grossmann SM, Machado VC, Xavier GM, et al. Demographic profile of odontogenic and selected nonodontogenic cysts in a Brazilian population. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007;104:e35-41.
  3. Tortorici S, Amodio E, Massenti MF, Buzzanca ML, Burruano F, Vitale F. Prevalence and distribution of odontogenic cysts in Sicily: 1986-2005. J Oral Sci 2008;50:15-8. https://doi.org/10.2334/josnusd.50.15
  4. Horowitz I, Bodner L. Use of xenograft bone with aspirated bone marrow for treatment of cystic defect of the jaws. Head Neck 1989;11:516-23. https://doi.org/10.1002/hed.2880110608
  5. Dodde R 2nd, Yavuzer R, Bier UC, Alkadri A, Jackson IT. Spontaneous bone healing in the rabbit. J Craniofac Surg 2000;11:346-9. https://doi.org/10.1097/00001665-200011040-00013
  6. Hjorting-Hansen E, Andreasen JO. Incomplete bone healing of experimental cavities in dog mandibles. Br J Oral Surg 1971;9:33-40. https://doi.org/10.1016/S0007-117X(71)80006-9
  7. Schuckert KH, Jopp S, Teoh SH. Mandibular defect reconstruction using three-dimensional polycaprolactone scaffold in combination with platelet-rich plasma and recombinant human bone morphogenetic protein-2: de novo synthesis of bone in a single case. Tissue Eng Part A 2009;15:493-9.
  8. Ogose A, Hotta T, Hatano H, et al. Histological examination of beta-tricalcium phosphate graft in human femur. J Biomed Mater Res 2002;63:601-4. https://doi.org/10.1002/jbm.10380
  9. Urist MR. Bone: formation by autoinduction. Science 1965;150:893-9. https://doi.org/10.1126/science.150.3698.893
  10. Asahina I, Sampath TK, Hauschka PV. Human osteogenic protein-1 induces chondroblastic, osteoblastic, and/or adipocytic differentiation of clonal murine target cells. Exp Cell Res 1996;222:38-47. https://doi.org/10.1006/excr.1996.0005
  11. Matsushita N, Terai H, Okada T, et al. A new bone-inducing biodegradable porous beta-tricalcium phosphate. J Biomed Mater Res A 2004;70:450-8.
  12. Alam I, Asahina I, Ohmamiuda K, Enomoto S. Comparative study of biphasic calcium phosphate ceramics impregnated with rhBMP-2 as bone substitutes. J Biomed Mater Res 2001;54:129-38. https://doi.org/10.1002/1097-4636(200101)54:1<129::AID-JBM16>3.0.CO;2-D
  13. Jingushi S, Urabe K, Okazaki K, et al. Intramuscular bone induction by human recombinant bone morphogenetic protein- 2 with beta-tricalcium phosphate as a carrier: in vivo bone banking for muscle-pedicle autograft. J Orthop Sci 2002;7:490-4. https://doi.org/10.1007/s007760200085